Updated to include the newest drugs and those currently in development, this Fifth Edition is a comprehensive reference on the preclinical and clinical pharmacology of anticancer agents. Organized by drug class, the book provides the latest information on all drugs and biological agents—their mechanisms of action, interactions with other agents, toxicities, side effects, and mechanisms of resistance. The authors explain the rationale for use of drugs in specific schedules and combinations and offer guidelines for dose adjustment in particular situations. This edition's introduction includes timely information on general strategies for drug usage, the science of drug discovery and development, economic and regulatory aspects of cancer drug development, and principles of pharmacokinetics. Eight new chapters have been added and more than twenty have been significantly revised. A companion website includes the fully searchable text and an image bank.
Cancer Chemotherapy & Biotherapy: Principles and Practice
Winer EP, Hudis C, Burstein HJ, et al. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.
This new edition of the Chemotherapy and Biotherapy Guidelines and Recommendations for Practice has been revised and updated to reflect the current procedures and practices in your specialty.
These guidelines explain and reference standards that oncology nurses should be aware of and follow. This book is an essential resource to enhance your care of patients with cancer.
This fifth revised edition describes the tremendous progress that has been made in recent years using biologicals in cancer treatment. This book summarizes an evolving science and a rapidly changing medical practice in biotherapy.
While referencing advances in traditional therapies and treatments such as chemotherapy, this book also highlights advances in biotherapy including research using Interferon and Super Interferon, HecI based and liposome based therapy, gene ...
The Pediatric Chemotherapy and Biotherapy Provider Program is a 2-day course designed to provide nurses with the knowledge base needed to safely care for children and adolescents receiving chemotherapy or biotherapy.
Clarkson B , O'Connor A , Winston L , et al : The physiologic disposition of 5 - fluorouracil and 5 - fluoro - 2 ... Seifert P , Baker L , Reed ML , et al : Comparison of continuously infused 5 - fluorouracil with bolus injection in ...
The editors have built Issues in Cancer Drugs and Therapies: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Gene Therapy in this book to be deeper than what you can access anywhere ...
Provides case studies addressing oncology issues focusing on chemotherapy and biotherapy scenarios.